BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32925054)

  • 1. Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease.
    Bergeron D; Beauregard JM; Soucy JP; Verret L; Poulin S; Matias-Guiu JA; Cabrera-Martín MN; Bouchard RW; Laforce R
    J Alzheimers Dis; 2020; 77(4):1569-1577. PubMed ID: 32925054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease.
    Scheltens NME; van der Weijden K; Adriaanse SM; van Assema D; Oomen PP; Krudop WA; Lammertsma AA; Barkhof F; Koene T; Teunissen CE; Scheltens P; van der Flier WM; Pijnenburg YAL; Yaqub M; Ossenkoppele R; van Berckel BNM
    Neuroimage Clin; 2018; 19():625-632. PubMed ID: 29984170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?
    Teipel S; Grothe MJ;
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):526-36. PubMed ID: 26555082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
    Bergeron D; Sellami L; Poulin S; Verret L; Bouchard RW; Laforce R
    Dement Geriatr Cogn Disord; 2020; 49(5):518-525. PubMed ID: 33207355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.
    Chételat G; Ossenkoppele R; Villemagne VL; Perrotin A; Landeau B; Mézenge F; Jagust WJ; Dore V; Miller BL; Egret S; Seeley WW; van der Flier WM; La Joie R; Ames D; van Berckel BN; Scheltens P; Barkhof F; Rowe CC; Masters CL; de La Sayette V; Bouwman F; Rabinovici GD
    Brain; 2016 Sep; 139(Pt 9):2528-39. PubMed ID: 27357349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
    Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
    Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of
    Zhang Q; Fan C; Wang L; Li T; Wang M; Han Y; Jiang J;
    Geroscience; 2024 Feb; 46(1):1407-1420. PubMed ID: 37610594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metabolic signatures across the Alzheimer's disease spectrum.
    Sala A; Caprioglio C; Santangelo R; Vanoli EG; Iannaccone S; Magnani G; Perani D
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):256-269. PubMed ID: 31811345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
    Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.
    Bailly M; Destrieux C; Hommet C; Mondon K; Cottier JP; Beaufils E; Vierron E; Vercouillie J; Ibazizene M; Voisin T; Payoux P; Barré L; Camus V; Guilloteau D; Ribeiro MJ
    Biomed Res Int; 2015; 2015():583931. PubMed ID: 26346648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    Moodley KK; Perani D; Minati L; Della Rosa PA; Pennycook F; Dickson JC; Barnes A; Contarino VE; Michopoulou S; D'Incerti L; Good C; Fallanca F; Vanoli EG; Ell PJ; Chan D
    J Alzheimers Dis; 2015; 46(3):639-53. PubMed ID: 26402512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein synthesis in the posterior cingulate cortex in Alzheimer's disease.
    Yoshida T; Kazui H; Tokunaga H; Kito Y; Kubo Y; Kimura N; Morihara T; Shimosegawa E; Hatazawa J; Takeda M
    Psychogeriatrics; 2011 Mar; 11(1):40-5. PubMed ID: 21447108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaschisis-Like Association of Hippocampal Atrophy and Posterior Cingulate Cortex Hypometabolism in Cognitively Normal Elderly Depends on Impaired Integrity of Parahippocampal Cingulum Fibers.
    Fischer FU; Wolf D; Fellgiebel A;
    J Alzheimers Dis; 2017; 60(4):1285-1294. PubMed ID: 29036815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Silva-Rodríguez J; Labrador-Espinosa MA; Moscoso A; Schöll M; Mir P; Grothe MJ;
    Brain; 2023 Nov; 146(11):4520-4531. PubMed ID: 37284793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.
    Huang SH; Hsiao WC; Chang HI; Ma MC; Hsu SW; Lee CC; Chen HJ; Lin CH; Huang CW; Chang CC
    BMC Med Imaging; 2024 Mar; 24(1):75. PubMed ID: 38549082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
    Baran TM; Lin FV;
    J Alzheimers Dis; 2018; 66(1):307-318. PubMed ID: 30282358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.